The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction

Hellenic Journal of Cardiology

Volumn 47, Issue 4, 2006, Pages 218-222

  Tsakiris, Alexandros K ^a   Marnelos, Panagiotis G ^a,b   Nearchou, Nearchos S ^a   Papadakis, John E ^a   Karatzis, Emmanouil N ^a   Skoufas, Panagiotis D ^a  

^a RED CROSS HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Creactive protein; Inflammation; Myocardial infarction; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CREATINE KINASE; FIBRINOLYTIC AGENT; HEPARIN; LACTATE DEHYDROGENASE; RETEPLASE; TENECTEPLASE; TROPONIN T; BIOLOGICAL MARKER; CREATINE KINASE MB; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; BLOOD; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYMOLOGY; HEART MUSCLE CONDUCTION SYSTEM; HEART STROKE VOLUME; HOSPITAL ADMISSION; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART CONDUCTION SYSTEM; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TROPONIN I;

EID: 35448932760     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
2. Pietilä K, Harmoinen A, Poyhonen L, et al: Intravenous streptokinase treatment and plasma C-reactive protein in patients with acute myocardial infarction. Br Heart J 1987; 58: 225-229.
3. Anzai T, Yoshikawa T, Shiraki H, et al: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q wave acute myocardial infarction. Circulation 1997; 96: 778-784.
4. Pietilä K, Harmoinen A, Teppo AM: Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Intern Med 1991; 23: 529-535.
5. Foussas SG, Zairis MN, Lyras AG, et al: Early prognostic usefulness of C-reactive protein added to the thrombolysis in myocardial infarction risk score in acute coronary syndromes. Am J Cardiol 2005; 96: 533-537.
6. Zairis MN, Manousakis SJ, Stefanidis AS, et al: C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 2002; 144: 782-789.
7. Antman EM: Braunwald E: ST-elevation myocardial infarction: Pathology, pathophysiology, and clinical features. Braunwald's Heart Disease, 7th edition. Elsevier Saunders, Philadelphia, 2005; pp 1141-1163.
8. Chesebro JH, Knatterud G, Roberts R, et al: Thrombolysis In Myocardial Infarction (TIMI) trial, phase 1. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
9. Correia LC, Lima JC, Gerstenblith G, et al: Correlation between turbidimetric and nephelometric methods of measuring C-reactive protein in patients with unstable angina or non-ST elevation acute myocardial infarction. Arq Bras Cardiol 2003; 81: 133-136.
10. Karatzis EN: The role of inflammatory agents in endothelial function and their contribution to atherosclerosis. Hellenic J Cardiol 2005; 46: 232-239.
11. Buffon A, Biasucci LM, Liuzzo G, et al: Widespread coronary inflammation in unstable angina. N Eng J Med 2002; 347: 5-12.
12. Dedobbeleer C, Melot C, Renard M: C-reactive protein increase in acute myocardial infarction. Acta Cardiol 2004; 59: 291-296.
13. Adams J 3rd, Abendschein D, Jaffe A: Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-763.
14. Liang RC, Xu YH: Relationship between serum CRP and creatine kinase isoenzyme in acute myocardial infarction. Human Yi Ke Da Xue Bao 2001; 26: 559-560.
15. Wilson AM, Ryan MC, Boyle AJ: The novel role of C-reactive protein in cardiovascular disease: Risk marker of pathogen. Int J Cardiol 2006; 106: 291-297.
16. Karatzis E, Lekakis J, Papamichael C, et al: Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. Int J Cardiol 2005; 101: 65-70.
17. Lekakis JP, Vamvakou G, Andreadou I, et al: Divergent effects of rofecoxib on endothelial function and inflammation in acute coronary syndromes. Int J Cardiol 2006 (in press).